Oklahoma Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 17 (81% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 3,819
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 39.81%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 755
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 32.83%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 57.87% 64.50%
White, Hispanic/Latino Patients 18.67% 12.98%
Black/African American, Non-Hispanic/Latino Patients 5.92% 4.90%
Black/African American, Hispanic/Latino Patients 0.31% 0.40%
Asian Patients3 0.55% 0.93%
American Indian/Alaska Native Patients3 6.57% 5.96%
Native Hawaiian/Other Pacific Islander Patients3 0.18% 0.26%
Patients with More than one race3 2.80% 3.05%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.27% 3.05%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.20% 1.19%
Unreported/Refused to Report Race and Ethnicity 2.64% 2.78%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 987
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 75.59%
COVID-19 Immunization Series Completed 430
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 48.12%
COVID-19 Immunization Series Additional 158
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 18.85%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 21.88% 44.88% 62.66%
White, Hispanic/Latino Patients 55.72% 24.65% 3.16%
Black/African American, Non-Hispanic/Latino Patients 4.05% 6.51% 3.16%
Black/African American, Hispanic/Latino Patients 0.20% 0.70% 1.27%
Asian Patients3 0.51% 0.47% 1.90%
American Indian/Alaska Native Patients3 1.72% 4.65% 3.80%
Native Hawaiian/Other Pacific Islander Patients3 0.20% 1.16% 0.00%
Patients with More than one race3 0.41% 1.16% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 4.96% 2.33% 1.27%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 6.79% 1.16% 9.49%
Unreported/Refused to Report Race and Ethnicity 3.55% 12.33% 13.29%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 23.53%
1 to 24 Hours 52.94%
More Than 24 Hours 23.53%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 5.88%
Staffing to administer the vaccine 17.65%
Vaccine confidence 41.18%
Vaccine storage capacity 5.88%
Vaccine supply 0.00%
Other 0.00%
None 41.18%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 101.76%
Average Percent of Health Center Visits Conducted Virtually 12.65%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 5.88%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 0
Number of School-Based Vaccination Sites 1

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 47.06%
None 52.94%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 11.76%
Patient awareness/education 23.53%
Staffing capacity 35.29%
Therapy administration/onsite logistics 35.29%
Other 5.88%
None 47.06%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021